Cargando…
Determination of the Prevalence of Postcovid Syndrome and Assessment of the Effectiveness of the Drug Cortexin in the Treatment of Neurological Disorders in Patients with Postcovid Syndrome. Results of the CORTEX Multicenter Clinical and Epidemiological Observational Program
Objectives. To study the prevalence and clinical manifestations of postcovid syndrome (PCS) in out-patients and to assess the efficacy of treatment with the drug Cortexin at doses of 10 and 20 mg i.m. for 10 days. Materials and methods. A total of 979 patients with PCS from regions of the Russian Fe...
Autores principales: | Putilina, M. V., Mutovina, Z. Yu., Kurushina, O. V., Khalilova, D. M., Saverskaya, E. N., Stepanova, S. B., Khoreva, M. A., Starikov, A. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596337/ https://www.ncbi.nlm.nih.gov/pubmed/36311877 http://dx.doi.org/10.1007/s11055-022-01307-2 |
Ejemplares similares
-
Postcovid Syndrome – The New Reality
por: Khoreva, M. A.
Publicado: (2022) -
Neurological Signs of Postcovid Syndrome
por: Kamchatnov, P. R., et al.
Publicado: (2022) -
Postcovid-19 Asthenic Syndrome
por: Zolotovskaia, I. A., et al.
Publicado: (2022) -
Clinical effectiveness of vortioxetine in postcovid syndrome
por: Vikarenko, M., et al.
Publicado: (2022) -
New treatment possibilities for postcovid hypogonadism and erectile dysfunction.
por: Knigavko, Oleksandr V., et al.
Publicado: (2022)